Company Lookup
عربي
Download Demo
 

Market News

This Month News

This Month News

send to a friend by email

PHARMACARE achieves net income of $1.64 million in 9M 2013

2013-11-03

According to Dar Al-Shifa Pharmaceuticals Company (PHARMACARE)’s data for the first nine months of the year, net profit after taxes reached 1,638,596 USD, PHARMACARE was listed on the PEX on April 23rd, 2012, and income for the prior similar reporting period has not been disclosed. Total assets of the company reached 35,385,469 USD as of September 30th, 2013, compared to total assets of 29,876,871 USD as of December 31st, 2012, a net increase of 18.4%. Total liabilities of the company reached 15,306,643 USD as of September 30th, 2013, compared to total liabilities of 10,932,921 USD as of December 31st, 2012, a net increase of 40.0%. Net ownership equity of the company reached 20,078,826 USD as of September 30th, 2013, compared with net ownership equity of 18,943,950 USD as of December 31st, 2012, a net increase of 6.0 in the first nine months.

 


 

2017-10-23
LADAEN realizes net loss of JD0.04 million in 9M 2017

2017-10-23
AZIZA posts net income of JD2.90 million in 9M 2017

2017-10-23
PIIC reports net income of JD4.91 million in 9M 2017

2017-10-23
PSE posts net income of $0.37 million in 9M 2017

2017-10-23
PEC posts net income of $6.35 million in 9M 2017

2017-10-23
ISBK reports net income of $9.44 million in 9M 2017

2017-10-23
PALAQAR reports net income of JD0.13 million in 9M 2017

2017-10-23
ARAB posts net income of JD0.05 million in 9M 2017

2017-10-23
TNB posts net income of $7.06 million in 9M 2017

2017-10-23
QUDS reports net income of $9.42 million in 9M 2017

2017-10-19
Scare liquidity amid the start of financial disclosures flow

2017-10-12
Al-Quds Bank records net income of $9.42 million in 9M 2017

2017-10-05
Optimism in the PEX with the start of October

 

 

 
Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013